Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.69
-0.11 (-0.62%)
Mar 10, 2026, 3:53 PM HKT

HKG:3378 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023
Period Ending
Mar '26 Dec '24 Dec '23
Debt / Equity Ratio
0.060.060.05
Net Debt / Equity Ratio
-0.75-0.75-0.59
Net Debt / EBITDA Ratio
1.391.393.11
Net Debt / FCF Ratio
1.461.463.37
Asset Turnover
0.000.00-
Quick Ratio
0.880.883.25
Current Ratio
1.231.234.75
Return on Equity (ROE)
-43.61%-43.61%-
Return on Assets (ROA)
-13.64%-13.64%-
Return on Capital Employed (ROCE)
-39.00%-39.00%-11.70%
Buyback Yield / Dilution
--49.83%-
Source: S&P Capital IQ. Standard template. Financial Sources.